Chembond Material Technologies Ltd

Chembond Material Technologies Ltd

₹ 182 1.42%
10 Jul - close price
About

Incorporated in 1974, Chembond Chemicals Ltd manufactures and sells specialty chemicals and animal health products.[1]

Key Points

Business Overview[1][2]
Chembond Material Technologies Limited manufactures specialty chemicals, including automotive sealants, engineering adhesives, metal treatment chemicals, high-performance coatings, and animal health & industrial biotech products. The Company serves diverse industries through its manufacturing facilities, R&D capabilities, and internationally certified quality systems.

  • Market Cap 245 Cr.
  • Current Price 182
  • High / Low 235 / 105
  • Stock P/E 17.2
  • Book Value 125
  • Dividend Yield 1.10 %
  • ROCE 10.8 %
  • ROE 8.84 %
  • Face Value 5.00

Pros

  • Company is almost debt free.
  • Company has been maintaining a healthy dividend payout of 25.4%

Cons

  • The company has delivered a poor sales growth of -1.82% over past five years.
  • Company has a low return on equity of 6.94% over last 3 years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
122.03 113.54 112.02 114.60 47.09 46.27 49.78 53.05 52.21 57.68 57.75 62.90 71.75
108.81 104.59 97.51 100.44 44.01 42.83 47.01 49.27 48.61 54.21 53.73 58.75 65.31
Operating Profit 13.22 8.95 14.51 14.16 3.08 3.44 2.77 3.78 3.60 3.47 4.02 4.15 6.44
OPM % 10.83% 7.88% 12.95% 12.36% 6.54% 7.43% 5.56% 7.13% 6.90% 6.02% 6.96% 6.60% 8.98%
1.67 3.01 9.31 3.59 0.89 2.09 5.16 0.19 1.72 2.65 0.13 -0.24 -1.19
Interest 0.50 0.26 0.46 0.32 0.20 0.16 0.16 0.18 0.14 0.07 0.10 0.13 0.07
Depreciation 1.31 1.06 1.47 1.38 0.88 0.57 0.69 0.68 0.70 0.68 1.20 0.81 0.85
Profit before tax 13.08 10.64 21.89 16.05 2.89 4.80 7.08 3.11 4.48 5.37 2.85 2.97 4.33
Tax % 22.48% 17.39% 29.79% 16.01% 47.75% 2.29% 11.16% -4.18% 25.22% 25.70% -34.39% 46.46% 19.86%
10.19 8.78 15.35 13.49 1.51 4.68 6.29 3.24 3.36 3.99 3.83 1.59 3.48
EPS in Rs 7.61 6.54 11.52 10.07 1.13 3.49 4.69 2.42 2.51 2.98 2.86 1.19 2.60
Raw PDF
Upcoming result date: 17 July 2026

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
299 270 291 327 301 268 274 349 440 178 201 250
273 259 274 304 275 258 256 332 405 172 188 231
Operating Profit 26 11 17 23 26 10 18 17 35 7 14 19
OPM % 9% 4% 6% 7% 8% 4% 7% 5% 8% 4% 7% 7%
1 189 18 11 4 3 15 9 5 14 9 1
Interest 4 2 1 1 1 1 0 1 1 1 1 0
Depreciation 4 4 4 4 4 4 5 4 5 3 3 4
Profit before tax 20 195 30 28 24 8 29 21 34 17 19 16
Tax % 28% 20% 24% 16% 19% 61% 28% 32% 26% 33% 10% 17%
14 156 23 24 20 3 20 14 25 11 18 13
EPS in Rs 9.24 114.66 14.43 16.40 12.93 1.40 15.18 10.39 18.73 8.34 13.10 9.62
Dividend Payout % 16% 4% 11% 11% 16% 144% 15% 48% 16% 42% 13% 21%
Compounded Sales Growth
10 Years: -1%
5 Years: -2%
3 Years: -17%
TTM: 24%
Compounded Profit Growth
10 Years: -7%
5 Years: -7%
3 Years: -16%
TTM: -12%
Stock Price CAGR
10 Years: 1%
5 Years: 2%
3 Years: -17%
1 Year: -18%
Return on Equity
10 Years: 6%
5 Years: 7%
3 Years: 7%
Last Year: 9%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity Capital 7 7 7 7 7 7 7 7 7 7 7 7
Reserves 89 200 223 242 255 262 286 297 315 137 149 160
25 11 9 9 7 3 2 2 7 7 3 4
83 72 82 68 54 50 59 56 74 41 43 48
Total Liabilities 203 289 321 325 322 322 354 361 402 191 202 219
51 47 49 108 109 124 122 121 116 26 34 41
CWIP 3 2 2 1 2 0 0 1 12 13 8 2
Investments 1 88 150 76 58 51 73 75 65 65 78 70
147 152 120 140 153 147 160 165 208 87 83 107
Total Assets 203 289 321 325 322 322 354 361 402 191 202 219

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
24 -27 5 -12 -12 24 25 -10 1 94 19 15
-3 52 -0 19 14 -12 -11 -2 1 -89 -8 -10
-18 -24 -3 -4 -6 -11 -2 -4 -2 -5 -9 -1
Net Cash Flow 3 1 2 3 -5 1 12 -16 0 0 2 3
Free Cash Flow 21 -24 -1 -74 -19 7 22 -14 -12 90 16 -5
CFO/OP 120% 102% 64% -13% -11% 310% 180% -17% 24% 1,490% 159% 67%

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Debtor Days 105 78 84 90 110 112 111 94 96 100 72 77
Inventory Days 60 46 59 46 58 77 82 67 53 58 56 54
Days Payable 96 86 95 96 84 96 120 76 81 118 113 95
Cash Conversion Cycle 70 38 49 40 84 94 73 84 67 40 15 36
Working Capital Days 45 90 42 44 82 98 83 78 70 39 25 47
ROCE % 18% 22% 12% 11% 9% 3% 10% 7% 10% 5% 12% 11%

Insights

In beta
Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Export Revenue (FOB Basis)
INR Lakhs ・Standalone data

Log in to view insights

Please log in to see hidden values.

Login
R&D Expenditure (Total)
INR Lakhs ・Standalone data
Number of Permanent Employees (Standalone)
Count ・Standalone data
Number of Manufacturing Plants
Count ・Standalone data
Number of Group Employees (Consolidated)
Count
Specialty Chemicals Segment Revenue (Consolidated)
INR Lakhs
Animal Health Segment Revenue (Consolidated)
INR Lakhs
R&D Headcount at Alandi (Scientists, Engineers, Chemists)
Count ・Standalone data

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
67.54% 67.54% 67.55% 67.55% 67.56% 67.61% 67.63% 67.65% 67.65% 67.65% 67.72% 68.08%
0.57% 0.59% 1.10% 0.94% 0.66% 0.69% 0.81% 0.61% 0.61% 0.61% 0.61% 0.61%
0.69% 0.69% 0.98% 1.18% 1.21% 1.18% 1.26% 1.32% 1.13% 0.74% 0.74% 0.74%
31.20% 31.18% 30.36% 30.32% 30.56% 30.52% 30.30% 30.42% 30.60% 31.00% 30.93% 30.58%
No. of Shareholders 9,4589,4809,81810,14510,84012,42913,40712,97913,48813,16812,67012,107

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents